Silicon carbide coating of nitinol stents to increase antithrombogenic properties and reduce nickel release

Cardiovascular Revascularization Medicine

Volumn 9, Issue 4, 2008, Pages 255-262

  Schmehl, Jörg M ^a   Harder, Claus ^b   Wendel, Hans P ^a   Claussen, Claus D ^a   Tepe, Gunnar ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Biotronik GmbH and Co KG   (Germany)

Author keywords

Coating; Nitinol; Silicon carbide; Stent; Thrombogenicity

Indexed keywords

BETA THROMBOGLOBULIN; ELASTASE; NICKEL; NITINOL; SILICON CARBIDE; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; CORONARY STENT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE COUNT; THROMBOGENESIS; THROMBUS;

ALLOYS; ANTITHROMBIN III; BETA-THROMBOGLOBULIN; BLOOD COAGULATION; BLOOD PLATELETS; CARBON COMPOUNDS, INORGANIC; COATED MATERIALS, BIOCOMPATIBLE; FIBRINOLYTIC AGENTS; HUMANS; KINETICS; LEUKOCYTE ELASTASE; MICROSCOPY, ELECTRON, SCANNING; NICKEL; PEPTIDE HYDROLASES; PROSTHESIS DESIGN; SILICON COMPOUNDS; SOLUBILITY; SPECTROPHOTOMETRY, ATOMIC; STENTS; SURFACE PROPERTIES;

EID: 53349141040     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2008.03.004     Document Type: Article

References (27)

1. Laird J. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 13 Suppl 2 (2006) II30-II40
2. Krankenberg H., Schluter M., Schofer J., and Tübler T. The femoral artery: the most complex peripheral vessel. Herz 31 (2006) 137-141
3. Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W., Schlager O., Cejna M., Lammer J., and Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
4. Schlager O., Dick P., Sabeti S., Amighi J., Mlekusch W., Minar E., and Schillinger M. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684
5. Duda S.H., Bosiers M., Lammer J., Scheinert D., Zeller T., Oliva V., Tielbeek A., Anderson J., Wiesinger B., Tepe G., Lansky A., Jaff M.R., Mudde C., Tielemans H., and Beregi J.P. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13 (2006) 701-710
6. van der Vleuten P.A., Wijpkema J.S., van den Heuvel A.F., Bosma C.A., Jessurun G.A., and Tio R.A. Treatment synergy of silicon carbide-coated stenting and abciximab for complex coronary artery lesions: clinical results of a single-center study. Ital Heart J 5 (2004) 663-666
7. Hanekamp C., Koolen J., Bonnier H., Oldroyd K., de Boer M.J., Heublein B., Visser C., and Small Vessel Study Group. Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries. Am J Cardiol 93 (2004) 1233-1237
8. Hamm C.W., and Hugenholtz P.G. Silicon carbide-coated stents in patients with acute coronary syndrome. Catheter Cardiovasc Interv 60 (2003) 375-381
9. Unverdorben M., Sattler K., Degenhardt R., Fries R., Abt B., Wagner E., Koehler H., Scholz M., Ibrahim H., Tews K.H., Hennen B., Daemgen G., Berthold H.K., and Vallbracht C. Comparison of a silicon carbide coated stent versus a noncoated stent in humans: the Tenax- versus Nir-Stent Study (TENISS). J Interv Cardiol 16 (2003) 325-333
10. Rzany A., and Schaldach M. Smart material silicon carbide: reduced activation of cells and proteins on a-SiC:H-coated stainless steel. Prog Biomed Res 6 (2001) 182-194
11. Harder C., Rzany A., and Schaldach M. Coating of vascular stents with antithrombogenic amorphous silicon carbide. Prog Biomed Res 4 (1999) 71-77
12. Tepe G., Schmehl J., Wendel H.P., Schaffner S., Heller S., Gianotti M., Claussen C.D., and Duda S.H. Reduced thrombogenicity of nitinol stents-in vitro evaluation of different surface modifications and coatings. Biomaterials 27 (2006) 643-650
13. Sawyer P.N., and Pate J.W. Bio-electric phenomena as etiological agents in intravascular thrombosis. Surgery 34 (1953) 491-500
14. Baurschmidt P., and Schaldach M. The electrochemical aspects of the thrombogenicity of a material. J Bioeng 1 (1977) 261-278
15. Rzany A., Harder C., and Schaldach M. Silicon carbide as an anti-thrombogenic stent coating: an example of a science-based development strategy. Prog Biomed Res 5 (2000) 168-178
16. van Oeveren W. Reduced deposition of blood formed elements and fibrin onto amorphous silicon carbide coated stainless steel. Prog Biomed Res 4 (1999) 78-83
17. Monnink S.H., van Boven A.J., Peels H.O., Tigchelaar I., de Kam P.J., Crijns H.J., and van Oeveren W. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. J Investig Med 47 (1999) 304-310
18. Heublein B., Ozbek C., and Pethig K. Silicon carbide-coated stents: clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg 5 (1998) 32-36
19. Unverdorben M., Sippel B., Degenhardt R., Sattler K., Fries R., Abt B., Wagner E., Koehler H., Daemgen G., Scholz M., Ibrahim H., Tews K.H., Hennen B., Berthold H.K., Vallbracht C., and Tenax versus Nir Stent Study. Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcome. Am Heart J 145 (2003) e17
20. Scheinert D., Scheinert S., Sax J., Piorkowski C., Bräunlich S., Ulrich M., Biamino G., and Schmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
21. Mazumder M.M., De S., Trigwell S., Ali N., Mazumder M.K., and Mehta J.L. Corrosion resistance of polyurethane-coated nitinol cardiovascular stents. J Biomater Sci Polym Ed 14 (2003) 1351-1362
22. Endo K. Chemical modification of metallic implant surfaces with biofunctional proteins (Part 2). Corrosion resistance of a chemically modified NiTi alloy. Dent Mater J 14 (1995) 199-210
23. O'Brien B., Carroll W.M., and Kelly M.J. Passivation of nitinol wire for vascular implants-a demonstration of the benefits. Biomaterials 23 (2002) 1739-1748
24. Köster R., Vieluf D., Kiehn M., Sommerauer M., Kähler J., Baldus S., Meinertz T., and Hamm C.W. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356 (2000) 1895-1897
25. Ryhänen J., Niemi E., Serlo W., Niemelä E., Sandvik P., Pernu H., and Salo T. Biocompatibility of nickel-titanium shape memory metal and its corrosion behavior in human cell cultures. J Biomed Mater Res 35 (1997) 451-457
26. Ryhänen J., Kallioinen M., Tuukkanen J., Junila J., Niemelä E., Sandvik P., and Serlo W. In vivo biocompatibility evaluation of nickel-titanium shape memory metal alloy: muscle and perineural tissue responses and encapsule membrane thickness. J Biomed Mater Res 41 (1998) 481-488
27. Shih C.C., Lin S.J., Chen Y.L., Su Y.Y., Lai S.T., Wu G.J., Kwok C.F., and Chung K.H. The cytotoxicity of corrosion products of nitinol stent wire on cultured smooth muscle cells. J Biomed Mater Res 52 (2000) 395-403